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Introduction
In  1962,  the  Japanese  Society  of  Gastroenterological




































































































laris  propria,  or  ﬁbrosis  in  the  submucosal  or  deeper  layer)58  
o  the  mucosa  and/or  submucosa,  regardless  of  lymph  node
etastatic  status  [1].  The  need  to  deﬁne  this  category
f  gastric  cancer  is  related  to  the  difference  in  prognosis
etween  early  and  advanced  gastric  cancer.  The  prognosis
s  generally  favorable  in  early  gastric  cancers  after  radi-
al  surgery,  with  a  5-year  survival  rate  of  more  than  90%
2,3].  The  proportion  of  early  gastric  cancer  among  all  gas-
ric  cancers  has  increased  to  nearly  50%  in  Japan  and  Korea
4—6].  With  more  widespread  mass  screenings,  as  well  as
dvances  in  endoscopic  techniques  and  equipment,  similar
rends  have  been  observed  during  the  past  few  decades  in
hina.
According  to  the  Japanese  Gastric  Cancer  Association,
ndifferentiated  gastric  carcinoma  includes  poorly  differ-
ntiated  adenocarcinoma,  mucinous  adenocarcinoma  and
ignet  ring  cell  carcinoma  [7].  Signet  ring  cell  carcinomas
SRCs)  are  deﬁned  as  gastric  cancers  in  which  the  pre-
ominant  component  consists  of  isolated  or  small  groups
f  malignant  cells  containing  intracytoplasmic  mucins  [8].
enerally,  SRCs  and  poorly  differentiated  adenocarcinomas,
ucinous  adenocarcinoma  are  associated  with  an  ominous
utcome.  However,  the  prognostic  signiﬁcance  of  SRCs  his-
ologic  subtype  in  early  stage  remains  controversial.  Some
tudies  have  reported  that  SRCs  have  a  lower  incidence  of
ymph  node  metastasis  and  favorable  prognosis  than  other
ndifferentiated  cancer  histologic  subtypes  [9,10].  For  this
eason,  undifferentiated  early  gastric  carcinoma  includes
RCs  subtype  and  non-SRCs  subtype  should  be  investigated
eparately  with  regard  to  oncologic  outcomes.  The  aim
f  this  retrospective  study  was  to  compare  the  clinico-
athologic  features  and  outcomes  between  SRCs  group  and
on-SRCs  group  in  patients  undergoing  radical  resection  for
arly  gastric  cancer.
atients and methods
atients
nstitutional  review  board  approval  was  obtained  before
onducting  this  study.  A  total  of  334  patients  who  had  under-
one  radical  (R0)  gastrectomy  with  D2  lymph  node  dissection
or  histologically  proven  undifferentiated  early  gastric  can-
er  from  January  1994  to  December  2008  at  the  Department
f  Abdominal  Surgical  Oncology,  Cancer  Hospital  of  the  Chi-
ese  Academy  of  Medical  Sciences,  Peking  Union  Medical
ollege  were  selected  for  this  study.  Cases  with  recurrence
r  multifocal  gastric  cancer  were  excluded.  Histology  was
lassiﬁed  according  to  the  Japanese  Gastric  Cancer  Associ-
tion  [7].
All the  patients  routinely  underwent  an  upper  alimentary
ract  barium  meal  and  electronic  gastroscope  examination
efore  surgery  to  identify  the  diseased  region  and  the  patho-
ogic  type  to  conﬁrm  the  diagnosis  of  malignant  neoplasm  of
he  stomach  after  pathologic  examination.  The  preopera-
ive  routine  chest  X-ray,  abdominal  ultrasound,  and  upper
bdominal  CT  examination  showed  no  pulmonary,  hepatic,
r  other  distant  metastases  and  no  tumor  directly  invading
he  pancreas,  spleen,  liver,  or  colon.  Endoscopic  ultra-
ound  examination  was  not  performed  routinely.  All  patients
nderwent  radical  subtotal  or  total  gastrectomies,  depend-
ng  on  the  tumor  location  and  intraoperative  veriﬁcation  of
umor-free  resection  margins,  as  well  as  D2  lymphadenec-
omies.  Those  with  tumors  located  in  the  lower  third  of  the
tomach  underwent  distal  gastrectomy.  Patients  with  tumors
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astrectomy  or  total  gastrectomy  according  to  the  direc-
ion  of  the  tumor  invasion.  Proximal  gastrectomy  was  used
or  patients  with  tumors  in  the  upper  third  of  the  stom-
ch,  and  total  gastrectomy  was  used  for  those  with  tumors
ccupying  the  entire  stomach.  In  this  series,  distal  gastrec-
omy  was  performed  in  283  patients,  total  gastrectomy  was
erformed  in  33  patients,  and  proximal  gastrectomy  was
erformed  in  18  patients.  No  patient  has  received  neoadju-
ant  therapy  before  surgery.  The  methods  of  reconstruction
fter  distal  gastrectomy  include  Billroth  I,  II  or  Roux-en-
.  Roux-en-Y  reconstruction  and  jejunal  interposition  are
he  most  common  methods  used  after  a total  gastrectomy.
ll  specimens  were  examined  after  resection.  World  Health
rganization  criteria  for  histological  typing  of  gastric  tumors
ere  used,  where  signet  ring  cell  carcinoma  is  deﬁned  as  an
denocarcinoma  in  which  a predominant  component  (more
han  50%  of  the  tumor)  is  made  up  of  isolated  or  small
roups  of  malignant  cells  containing  intracytoplasmic  mucin.
he  formalin-ﬁxed  specimens  were  cut  into  multiple  slices,
rincipally  parallel  to  the  lesser  curvature,  at  an  inter-
al  of  3  mm.  The  hematoxylin  and  eosin  stained  sections
f  tumor  were  examined.  A  single  pathologist  retrieved  all
ymph  nodes  by  palpation  under  gross  inspection.  The  lymph
odes  were  cut  into  two  pieces  along  the  long  axis,  embed-
ed  in  parafﬁn  blocks,  and  stained  with  haematoxylin  and
osin.
Of  these  patients,  SRCs  group  had  115  patients  (34.4%),
nd  non-SRCs  had  219  patients  (65.6%).  The  patients’  clinical
haracteristics,  histopathological  parameters  and  follow-
p  data  were  analyzed.  Clinicopathological  factors,  such
s  sex-ratio,  age,  tumor  size,  tumor  location,  macroscopic
ppearance,  histological  type,  ulceration,  depth  of  tumor
nvasion,  lymph  node  status  and  lymphovascular  invasion
ere  deﬁned  according  to  the  Japanese  Classiﬁcation  of
astric  Carcinoma  [7]. The  maximum  diameter  of  tumor  was
ecorded  as  tumor  size.  Macroscopic  type  includes  elevated
I,  protruded;  IIa,  superﬁcial  elevated),  ﬂat  (IIb,  superﬁcial
at),  and  depressed  (IIc,  superﬁcial  depressed;  III,  exca-
ated).  Lesions  with  ulceration  or  scarring  from  previous
lceration  (converging  folds  or  deformity  of  the  muscu-ithin  them  were  regarded  as  ulcerated  lesions.  The  depth
f  tumor  invasion  was  classiﬁed  as  mucosa  and  submu-
osa  carcinoma.  Lymphovascular  invasion  was  deﬁned  as  the
resence  of  tumor  emboli  either  in  the  lymphatic  duct  or  the
ascular  lumen.  Overall  survival  and  the  pattern  of  recur-
ence  were  compared  between  the  two  groups.  Patients  with
RCs  were  considered  as  the  reference  group  for  statistical
nalysis.
ollow-up
ll  patients  who  survived  the  operation  were  followed  until
eath  or  the  cutoff  date  (March  31,  2014).  All  patients
ere  followed  up  regularly  at  3-month  intervals  in  the
rst  2  years  and  the  every  6  months  thereafter  for  clini-
al  examination  including  chest  X-ray,  abdominal  and  pelvic
ltrasound  or  CT  and  tumor  markers.  Follow-up  evaluation
as  implemented  by  means  of  outpatient  service,  telephone
alls,  and  letters.  Median  follow-up  period  were  97  months
range,  66—236).  Only  deaths  due  to  early  gastric  cancer
ere  considered.  Deaths  due  to  other  causes  were  cen-
ored  at  the  date  of  death.  Three  patients  were  lost  to
ollow-up.  These  patients  were  excluded  from  the  present
tudy.
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Table  1  Comparison  of  clinicopathologic  features  between  patients  with  SRCs  and  non-SRCs  types.
Variable  Total  (%)  SRCs  group  (%)  Non-SRCs  group  (%)  P-value
Sex  0.372
Male  201  (62.9)  73  (63.5)  128  (54.4)
Female  133  (37.1)  42  (36.5)  91  (41.5)
Age  (years)  0.849
≤  60  221  (66.2)  62  (53.9)  119  (54.3)
>  60  113  (33.8)  53  (46.1)  100  (45.7)
Tumor  size  (mm)  0.609















6  (9>  20  172  (51.5)  5
Tumor  location  
Upper  20  (6.0)  
Middle  79  (23.7)  3
Lower  235  (70.3)  8
Macroscopic  type
Elevated  36  (10.8)
Flat  70  (21.0)  1
Depressed  228  (68.2) 9
Ulcer  
Presence  118  (35.3)  1
Absence  216  (64.7)  9
Depth  of  invasion  
Mucosa  170  (50.9)  6
Submucosa  164  (49.1)  5
Lymphovascular  invasion  
Presence  18  (5.4)  
Absence  316  (94.6)  10
Lymph  node  metastasis
Presence  48  (14.4)  
Absence  286  (85.6)  10
Statistical analysis
Statistical  analysis  were  performed  with  SPSS  software,
version  15.0  for  Windows  (SPSS  Inc.,  Chicago,  IL,  USA).
Results  were  given  as  percentages,  mean  and  standard
deviations,  or  median  and  ranges.  Quantitative  and  quali-
tative  variables  were  compared  with  the  Student  t  test  and
2 test,  respectively.  Overall  survival  data  were  analyzed
using  the  Kaplan-Meier  method.  The  log-rank  test  was  used
to  compare  survival  curves.  The  Cox  proportional  hazards
regression  model  was  used  to  identify  prognostic  factors.
Step-forward  regression  was  used  to  build  a  valid  statistical
model  for  the  association  of  prognostic  factors  with  over-
all  survival  among  patients.  P-value  of  less  than  0.05  was
considered  statistically  signiﬁcant.
Results
Clinicopathologic features
We  compared  the  clinicopathologic  features  of  patients
with  different  histologic  types  of  cancer  (Table  1).  The  two
groups  were  comparable  for  age  and  sex.  Despite  more
frequent  ulcer  ﬁndings  and  the  presence  of  lymph  node
metastasis  ([15.7%  vs  45.7%;  P  =  0.001];  [6.9%  vs  18.3%;
P  = 0.005])  in  the  non-SRCs  group,  tumor  size  (P  =  0.609),
tumor  location  (P  =  0.537),  macroscopic  type  (P  =  0.092),
depth  of  invasion  (P  =  0.813),  and  lymphovascular  invasion9.6)  115  (52.5)
0.537
.3)  15  (6.8)
6.1)  49  (22.4)
9.6)  155  (70.8)
0.092
.0) 16  (7.3)
3.0)  50  (22.8)
0.0)  153  (69.9)
0.001
5.7)  100  (45.7)
4.3)  119  (54.3)
0.813
4.8)  117  (53.4)
5.2)  102  (46.6)
0.358
.0)  10  (4.6)
3.0)  209  (95.4)
0.005
.5)  39  (17.8)
1.5)  180  (82.2)
(P  =  0.358)  were  similar  between  the  SRCs  and  non-SRCs
groups.
RecurrenceLocoregional  recurrence  included  cancer  recurrence  within
the  regional  resection  area,  local  anastomotic  sites,
or  peritoneal  recurrence.  A  peritoneal  recurrence  was
any  recurrence  within  the  abdominal  cavity  resulting  in
intraperitoneal  implantation.  Distant  recurrence  included
liver  metastasis,  metastasis  at  other  extra-abdominal  sites,
and  nodal  metastasis  beyond  the  regional  nodes.  In  the  SRCs
group,  recurrence  occurred  for  12  patients,  7  of  whom  died.
In  the  non-SRCs  group,  recurrence  occurred  for  43  patients,
31  of  whom  died.  The  incidence  of  recurrence  for  SRCs  group
was  signiﬁcantly  lower  than  that  for  non-SRCs  group  (10.4%
vs  19.6%;  P <  0.05).
Survival
The  overall  5-year  survival  rate  was  88.6%  in  all  cases.  The
overall  survival  rate  of  patients  in  SRCs  group  was  signiﬁ-
cantly  better  than  that  of  patients  in  non-SRCs  group  (5-year
survival,  93.9%  vs  85.8%;  P  =  0.027).  Univariate  analysis  of
overall  5-year  survival  showed  that  SRCs  subtype,  lympho-
vascular  invasion,  and  lymph  node  metastasis  signiﬁcantly
affected  patient  prognosis  (Table  2).  The  multivariate  Cox
proportional  regression  analysis  revealed  that  SRCs  subtype,
lymphovascular  invasion,  and  lymph  node  metastasis  were
independent  prognostic  factors  (Table  3).
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Table  2  Univariate  analysis  of  factors  related  to  the  prognosis  of  early  gastric  cancer.
Factor  n  5-year  survival  rate  (%)  P-value
SRCs  subtype  0.027
No  219  85.8
Yes  115  93.9
Sex  0.511
Male  201  89.6
Female  133  87.2
Age(years)  0.131
≤  60  221  90.5
>  60  113  84.9
Tumor  Size  (mm)  0.402
≤  20  162  90.1
>  20  172  87.2
Tumor  Location  0.868
Upper  20  85.0
Middle  79  88.6
Lower  235  88.9
Macroscopic  Type 0.999
Elevated  36  88.9
Flat  70  88.5




















Presence  118  
Absence  216  
Depth  of  Invasion  
Mucosa  170  
Submucosa  164  
Lymphovascular  invasion
Presence  18  
Absence  316  
Lymph  node  metastasis  
Presence  48  
Absence  286  
Table  3  Cox  multiple  regression  analysis  of  overall  surviv
Factor  Regression  coefﬁcient  SRC  type  1.182  0
Ulcer  0.912  0
Submucosal  Invasion  0.725  0
Lymphovascular  invasion 0.610  0
Lymph  node  metastasis 1.542 0
iscussion
astric  carcinoma  is  the  major  cause  of  cancer  related
eaths  in  China.  The  prognosis  is  different  between  early
nd  advanced  gastric  cancer.  Previous  study  identiﬁed  that
istologic  type  was  one  of  the  signiﬁcant  factors  predicting
rognosis  [11].  Tumors  with  undifferentiated  ﬁndings  on
istological  examination  are  generally  thought  to  have
reater  incidence  of  lymph  node  metastases  and  have  a
oor  prognosis.  Many  studies  included  SRCs  as  a  subgroup
f  undifferentiated  carcinomas  for  analyzing,  however,  the
linicopathologic  features  and  the  prognosis  of  SRCs  remain
ontroversial.  It  has  been  reported  that  the  majority  of
astric  cancers  with  SRC  histologic  subtype  were  diagnosed
t  an  advanced  stage,  peritoneal  carcinomatosis  was  sig-
iﬁcantly  more  frequent  in  SRC  patients,  and  consequently
eading  to  poorer  prognosis.  Piessen  et  al.  [12]  have  shown





























tandard  error  Hazard  ratio  (95%  CI)  P-value.243  2.142  (2.011—5.234)  0.001
.661  7.284  (3.463—8.425)  0.374
.615  1.997  (2.556—7.547)  0.102
.749  2.001  (1.023—3.245)  0.010
.314  2.243  (1.871—4.259)  0.005
redictor  of  poor  prognosis  after  R0  resection.  The  SRC
roup  fared  worse  in  both  early-stage  and  late-stage  groups.
ecently,  some  authors  reported  that  SRC  has  similar  or
etter  prognosis  compared  with  other  histologic  subtypes
n  early  stages  of  gastric  cancers.  Taghavi  et  al.  [13]
ound  that  SRC  portends  a similar  prognosis  at  all  stages
ompared  with  a  heterogeneous  group  of  non-SRC  gastric
denocarcinomas.  Another  study  found  no  difference  of  the
rognostic  signiﬁcance  of  SRC  in  stage-stratiﬁed  mortality
etween  SRC  and  well-differentiated  groups  [14].  So,  the
rognostic  signiﬁcance  of  signet  ring  gastric  cancer  needs
lariﬁcation.  In  this  study,  we  showed  that  SRC  lesions  had
 signiﬁcantly  lower  incidence  of  lymph  node  metastasis
nd  exhibit  favorable  prognosis  when  diagnosed  in  early
tage  after  surgery.  Also,  the  incidence  of  recurrence  for
RCs  was  lower  than  that  for  non-SRCs.
In  our  study,  SRCs  were  more  frequently  observed  in
ounger  patients  compared  with  non-SRCs.  Some  reports
[[Early  gastric  cancer  with  signet  ring  cell  histology  
assumed  that  better  survival  may  be  related  to  the  younger
age  that  is  common  in  SRC  patients  [15]. Ulceration  was
more  frequently  found  in  non-SRCs  group.  It  has  been
reported  that  ulcerative  ﬁnding  is  one  of  the  independent
factors  predicting  more  lymph  node  metastasis  and  worse
survival  in  several  studies  [16,17].  It  has  been  reported  that
SRC  tumors  show  tendencies  to  be  larger  and  to  spread
superﬁcially  to  mucosal  layers,  but  our  study  did  not  ﬁnd
this  result.
More  and  more  evidence  suggests  that  gastric  cancer  is
a  heterogeneous  disease  whose  behavior  is  dependent  on
tumor  histopathology.  The  presence  of  SRC  histology  should
not  be  uniformly  considered  a  poor  prognostic  feature.  SRC
familial  syndrome  linked  to  the  CDH1  gene  mutation.  Early
SRCs  are  characterized  by  a  latent  state  with  low  aggres-
siveness,  in  contrast,  when  SRC  has  invaded  the  muscular
layer,  an  accelerated  tumor  process  leads  to  diffuse  tumor
invasiveness,  associated  with  a  greater  risk  of  spread  to
lymph  nodes  and  peritoneal  surfaces  and  is  linked  to  poor
chemosensitivity  and  prognosis  [18].
In  our  study,  SRCs  had  a  signiﬁcantly  lower  incidence  of
lymph  node  metastasis  and  a  signiﬁcantly  better  prognosis.
These  data  does  raise  the  question  of  whether  local  therapy
such  as  endoscopic  resection  for  early  gastric  cancer  with
SRC  would  provide  equivalent  results.  Endoscopic  treatment
deserves  to  be  concerned  about  and  should  be  investigated
in  further  analyses.  Because  our  research  was  a  retrospec-
tive  study  in  single  institution  with  relatively  smaller  cases,
it  is  reasonable  to  expect  that  useful  information  could  be
obtained  by  large-scale  prospective  studies.
In  summary,  the  present  study  demonstrated  that  despite
SRC  tumors  being  classiﬁed  as  undifferentiated,  their  behav-
ior  differed  compared  with  poorly  differentiated  adenocar-
cinoma  and  mucinous  adenocarcinoma  tumors.  SRCs  had  a
signiﬁcantly  lower  incidence  of  lymph  node  metastasis  and
a  signiﬁcantly  better  prognosis  in  early  stage.  Our  ﬁndings
have  important  prognostic  implications  that  may  improve
treatment  and  follow-up  strategies  after  radical  surgery.
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